世界の外科的止血剤・内部組織シーラント・接着バリア市場 2019年

【英語タイトル】Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Professional Survey Report 2019

QYResearchが出版した調査資料(QYR20FB02699)・商品コード:QYR20FB02699
・発行会社(調査会社):QYResearch
・発行日:2019年11月(※2024年版があります。お問い合わせください)
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,036,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートは、外科的止血剤・内部組織シーラント・接着バリアの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、止血剤、内部組織シーラント、接着バリアに、用途別には、病院、診療所および外傷センター、外来手術センターにセグメント区分し、外科的止血剤・内部組織シーラント・接着バリアの世界市場を分析しました。


・エグゼクティブ・サマリー
・外科的止血剤・内部組織シーラント・接着バリアの世界市場概要
・外科的止血剤・内部組織シーラント・接着バリアの製造コスト構成分析
・外科的止血剤・内部組織シーラント・接着バリアの開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・外科的止血剤・内部組織シーラント・接着バリアの地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・外科的止血剤・内部組織シーラント・接着バリアのセグメント分析(種類別)
(止血剤、内部組織シーラント、接着バリア)
・外科的止血剤・内部組織シーラント・接着バリアのセグメント分析(用途別)
(病院、診療所および外傷センター、外来手術センター)
・外科的止血剤・内部組織シーラント・接着バリアの主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Baxter、Ethicon、B. Braun Melsungen、Sanofi、C. R. Bard、Integra Lifesciences、Cryolife、Tissuemed、Cohera Medical、Pfizer)
・外科的止血剤・内部組織シーラント・接着バリアの市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

Increasing geriatric population across the globe coupled with increasing demand for cardiovascular, orthopaedic, digestive, and other surgical procedures is expected to fuel consumption of surgical hemostats, internal tissue sealants and adhesion barriers market.Primary factors fuelling demand for surgical hemostats, internal tissue sealants and adhesion barriers are rapidly ageing population with rising cardiovascular, digestive, orthopaedic and other surgical procedures, strong healthcare consciousness and availability of new surgical adhesives for various surgical application.

The global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Baxter
Ethicon
B. Braun Melsungen
Sanofi
C. R. Bard
Integra Lifesciences
Cryolife
Tissuemed
Cohera Medical
Pfizer

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Hemostats
Internal Tissue Sealants
Adhesion Barriers

Segment by Application
Hospitals
Clinics & Trauma Centers
Ambulatory Surgical Centers

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
1.1 Definition of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
1.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Segment by Type
1.2.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Hemostats
1.2.3 Internal Tissue Sealants
1.2.4 Adhesion Barriers
1.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Segment by Applications
1.3.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics & Trauma Centers
1.3.4 Ambulatory Surgical Centers
1.4 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Overall Market
1.4.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (2014-2025)
1.4.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production (2014-2025)
1.4.3 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2014-2025)
1.4.4 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2014-2025)
1.4.5 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2014-2025)
1.4.6 Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2014-2025)
1.4.7 Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2014-2025)
1.4.8 India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
2.3 Manufacturing Process Analysis of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
2.4 Industry Chain Structure of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers

3 Development and Manufacturing Plants Analysis of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
3.1 Capacity and Commercial Production Date
3.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production and Capacity Analysis
4.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Analysis
4.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Price Analysis
4.4 Market Concentration Degree

5 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Regional Market Analysis
5.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production by Regions
5.1.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production by Regions
5.1.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Regions
5.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption by Regions
5.3 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
5.3.1 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production
5.3.2 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Import and Export
5.4 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
5.4.1 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production
5.4.2 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Import and Export
5.5 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
5.5.1 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production
5.5.2 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Import and Export
5.6 Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
5.6.1 Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production
5.6.2 Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Import and Export
5.7 Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
5.7.1 Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production
5.7.2 Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Import and Export
5.8 India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
5.8.1 India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production
5.8.2 India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Import and Export

6 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Segment Market Analysis (by Type)
6.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production by Type
6.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Type
6.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Price by Type

7 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Segment Market Analysis (by Application)
7.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption by Application
7.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Market Share by Application (2014-2019)

8 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Major Manufacturers Analysis
8.1 Baxter
8.1.1 Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.1.2 Baxter Product Introduction, Application and Specification
8.1.3 Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Ethicon
8.2.1 Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.2.2 Ethicon Product Introduction, Application and Specification
8.2.3 Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 B. Braun Melsungen
8.3.1 B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.3.2 B. Braun Melsungen Product Introduction, Application and Specification
8.3.3 B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Sanofi
8.4.1 Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.4.2 Sanofi Product Introduction, Application and Specification
8.4.3 Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 C. R. Bard
8.5.1 C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.5.2 C. R. Bard Product Introduction, Application and Specification
8.5.3 C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Integra Lifesciences
8.6.1 Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.6.2 Integra Lifesciences Product Introduction, Application and Specification
8.6.3 Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Cryolife
8.7.1 Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.7.2 Cryolife Product Introduction, Application and Specification
8.7.3 Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Tissuemed
8.8.1 Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.8.2 Tissuemed Product Introduction, Application and Specification
8.8.3 Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Cohera Medical
8.9.1 Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.9.2 Cohera Medical Product Introduction, Application and Specification
8.9.3 Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Pfizer
8.10.1 Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.10.2 Pfizer Product Introduction, Application and Specification
8.10.3 Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market
9.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Trend Analysis
9.1.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size (Volume and Value) Forecast 2019-2025
9.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Regional Market Trend
9.2.1 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecast 2019-2025
9.2.2 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecast 2019-2025
9.2.3 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecast 2019-2025
9.2.4 Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecast 2019-2025
9.2.5 Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecast 2019-2025
9.2.6 India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecast 2019-2025
9.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Trend (Product Type)
9.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer



【掲載企業】

Baxter、Ethicon、B. Braun Melsungen、Sanofi、C. R. Bard、Integra Lifesciences、Cryolife、Tissuemed、Cohera Medical、Pfizer

★調査レポート[世界の外科的止血剤・内部組織シーラント・接着バリア市場 2019年] (コード:QYR20FB02699)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の外科的止血剤・内部組織シーラント・接着バリア市場 2019年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆